
Enanta Pharmaceuticals Inc
NASDAQ:ENTA

Intrinsic Value
The intrinsic value of one
ENTA
stock under the Base Case scenario is
17.56
USD.
Compared to the current market price of 5.95 USD,
Enanta Pharmaceuticals Inc
is
Undervalued by 66%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Enanta Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Enanta Pharmaceuticals Inc
Balance Sheet Decomposition
Enanta Pharmaceuticals Inc
Current Assets | 268.1m |
Cash & Short-Term Investments | 216.7m |
Receivables | 40.2m |
Other Current Assets | 11.3m |
Non-Current Assets | 80.5m |
PP&E | 77m |
Other Non-Current Assets | 3.5m |
Free Cash Flow Analysis
Enanta Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Enanta Pharmaceuticals Inc
Revenue
|
66.6m
USD
|
Operating Expenses
|
-176.9m
USD
|
Operating Income
|
-110.3m
USD
|
Other Expenses
|
5.4m
USD
|
Net Income
|
-104.9m
USD
|
ENTA Profitability Score
Profitability Due Diligence
Enanta Pharmaceuticals Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

Score
Enanta Pharmaceuticals Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.
ENTA Solvency Score
Solvency Due Diligence
Enanta Pharmaceuticals Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Score
Enanta Pharmaceuticals Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ENTA Price Targets Summary
Enanta Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ENTA
is 17.17 USD
with a low forecast of 8.08 USD and a high forecast of 22.05 USD.
Dividends
Current shareholder yield for ENTA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ENTA
stock under the Base Case scenario is
17.56
USD.
Compared to the current market price of 5.95 USD,
Enanta Pharmaceuticals Inc
is
Undervalued by 66%.